These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29983261)

  • 61. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
    Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Projecting long-term graft and patient survival after transplantation.
    Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA
    Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure?
    de Holanda MI; Matuck T; de Carvalho DDBM; Domingues EMFL; Curvo R; Glasberg DS; Santos AMG; Borela ÁM; Pôrto LC
    Transplant Proc; 2018 Apr; 50(3):728-736. PubMed ID: 29661425
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biological properties and therapeutic potential of bilirubin.
    McGeary RP; Szyczew AJ; Toth I
    Mini Rev Med Chem; 2003 May; 3(3):253-6. PubMed ID: 12570840
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bile pigments in pulmonary and vascular disease.
    Ryter SW
    Front Pharmacol; 2012; 3():39. PubMed ID: 22408625
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bilirubin as a Therapeutic Molecule: Challenges and Opportunities.
    Adin CA
    Antioxidants (Basel); 2021 Sep; 10(10):. PubMed ID: 34679671
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can bilirubin nanomedicine become a hope for the management of COVID-19?
    Khurana I; Allawadhi P; Khurana A; Srivastava AK; Navik U; Banothu AK; Bharani KK
    Med Hypotheses; 2021 Apr; 149():110534. PubMed ID: 33640714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Impact of Health Resort Treatment on the Nonenzymatic Endogenous Antioxidant System.
    Kuciel-Lewandowska J; Kasperczak M; Bogut B; Heider R; Laber WT; Laber W; Paprocka-Borowicz M
    Oxid Med Cell Longev; 2020; 2020():8423105. PubMed ID: 32089783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum Bilirubin Levels in Overweight and Obese Individuals: The Importance of Anti-Inflammatory and Antioxidant Responses.
    Žiberna L; Jenko-Pražnikar Z; Petelin A
    Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients.
    Tsai MT; Tarng DC
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597982
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
    Zhang L; Yang J; Deng M; Xu C; Lai C; Deng X; Wang Y; Zhou Q; Liu Y; Wan L; Li P; Fang J; Hou J; Lai X; Ma F; Li N; Li G; Kong W; Zhang W; Li J; Cao M; Feng L; Chen Z; Chen L; Ji T
    Sci Rep; 2023 May; 13(1):7263. PubMed ID: 37142713
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease.
    Bates EA; Kipp ZA; Martinez GJ; Badmus OO; Soundarapandian MM; Foster D; Xu M; Creeden JF; Greer JR; Morris AJ; Stec DE; Hinds TD
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The physiology of bilirubin: health and disease equilibrium.
    Vitek L; Hinds TD; Stec DE; Tiribelli C
    Trends Mol Med; 2023 Apr; 29(4):315-328. PubMed ID: 36828710
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance.
    Kipp ZA; Xu M; Bates EA; Lee WH; Kern PA; Hinds TD
    Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671031
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease.
    Marghani BH; El-Adl M; Ateya AI; Othman BH; Ghamry HI; Shukry M; Soliman MM; Rizk MA
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295901
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.
    Badmus OO; Hillhouse SA; Anderson CD; Hinds TD; Stec DE
    Clin Sci (Lond); 2022 Sep; 136(18):1347-1366. PubMed ID: 36148775
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum bilirubin as a predictor of graft outcomes after renal transplant.
    Magsi R; Shetty N; Giffen Z; Saltzman B; Nadiminty N; Ekwenna O; Rees M; Sindhwani P
    Am J Clin Exp Urol; 2022; 10(1):37-43. PubMed ID: 35291414
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin.
    Thomas DT; DelCimmuto NR; Flack KD; Stec DE; Hinds TD
    Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK-SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue.
    Hinds TD; Kipp ZA; Xu M; Yiannikouris FB; Morris AJ; Stec DF; Wahli W; Stec DE
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.